Published in

F1000 - Post-publication peer review of the biomedical literature, 2019

DOI: 10.3410/f.732570091.793559737

Links

Tools

Export citation

Search in Google Scholar

F1000Prime recommendation of Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.

Dataset published in 2019 by Jeremy Chataway, Nevin John ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload
Beta version